Paola Izquierdo, APRN
Family · Pembroke Pines, FLNPI 1205234135
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.4%. Reporting peaked in 2021 at $2,516 and has fallen 80.2% since, to $499 in 2025. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $71.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mirati Therapeutics, Inc.$1K
- Janssen Scientific Affairs, LLC$1K
- Genentech, Inc.$900
- Pfizer$831
- Daiichi Sankyo Inc.$598
- AstraZeneca$562
- plus $3K from 17 others
What the payments were for
- Consulting fees$2,63033%
- Speaking & faculty fees$7209%
- Food & beverage$4,60158%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mirati Therapeutics, Inc. | 3 | $1,064 |
| Janssen Scientific Affairs, LLC | 5 | $1,022 |
| Genentech, Inc. | 1 | $900 |
| Pfizer | 3 | $831 |
| Daiichi Sankyo Inc. | 24 | $598 |
| AstraZeneca | 6 | $562 |
| Jazz Pharmaceuticals Inc. | 9 | $554 |
| Amgen | 12 | $511 |
| Johnson & Johnson | 8 | $415 |
| Novartis | 21 | $316 |
| E.r. Squibb & Sons, L.L.C. | 3 | $213 |
| Tempus AI, Inc | 3 | $164 |
| Lilly USA, LLC | 2 | $147 |
| Novocure Inc. | 2 | $124 |
| Caris MPI, Inc. | 2 | $112 |
| Regeneron Healthcare Solutions, Inc. | 1 | $97 |
| Coherus Oncology, Inc. | 1 | $94 |
| Merck | 1 | $85 |
| Genentech USA, Inc. | 1 | $69 |
| G1 Therapeutics, Inc. | 1 | $20 |
| Clovis Oncology, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,955 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 25 | $535 |
| Prochlorperazine Maleate | 16 | $172 |
| Tramadol Hcl | 20 | $89 |
| Folic Acid | 26 | $89 |
| Ciprofloxacin Hcl | 11 | $85 |
| Prednisone | 18 | $68 |
| Azithromycin | 13 | $54 |
| Potassium Chloride | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other family in Pembroke Pines
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.